Gibson Christopher
SEC Form 4 insider trading activity
Gibson Christopher has filed 22 SEC Form 4 filings (51 transaction rows) across 2 companies, including RXRX, PACB, with disclosures dating back to 2025. 22 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
On the most recent filing, Gibson Christopher is listed as Director at RECURSION PHARMACEUTICALS, INC. Inside the rolling window, Gibson Christopher reported no open-market purchases and 18 open-market sales totaling $4.3M in RXRX. The largest disclosed transaction in the window is a sale of 100,000 RXRX shares on Oct 10, 2025, worth $604K.
Companies traded
Other insiders at RXRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.3M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| RXRX | Director | Sale | 40,000 | $145K | Jun 5 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $123K | May 27 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $135K | May 8 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $144K | Apr 24 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $124K | Apr 8 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $130K | Mar 25 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $138K | Feb 19 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $165K | Feb 6 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $179K | Jan 22 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $170K | Jan 7 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $180K | Dec 19 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $185K | Dec 5 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $166K | Nov 19 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $208K | Nov 6 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 100,000 | $570K | Oct 24 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 100,000 | $604K | Oct 10 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 100,000 | $476K | Sep 26 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 100,000 | $471K | Sep 12 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Gibson Christopher made?
Gibson Christopher has filed 22 SEC Form 4 filings (51 transaction rows) across 2 companies, including RXRX, PACB since 2025.
Which companies does Gibson Christopher trade?
Gibson Christopher has filed SEC Form 4 disclosures for 2 companies, including RXRX, PACB.
When was Gibson Christopher's most recent SEC Form 4 filing?
Gibson Christopher's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.
What is Gibson Christopher's total buy and sell value in the current window?
Inside the rolling retention window, Gibson Christopher bought $0 and sold $4.3M based on SEC Form 4 filings.
What was Gibson Christopher's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 RXRX shares on 2025-10-10, worth $604K, per SEC Form 4 filings.